Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02625402 · ClinicalTrials.gov registry record · NA
Pilot RCT Comparing Effectiveness of Two Decision Aids for Hip and Knee Osteoarthritis
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02625402: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02625402 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02625402, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
This pilot RCT study is to examine the comparative effectiveness of two decision aids for hip and knee osteoarthritis.
Primary Outcome
5 multiple choice knowledge items from the Hip and Knee Decision Quality Instruments will be averaged into a knowledge subscale score (0-100%) with higher scores indicating higher knowledge.
Interventions
- BEHAVIORAL Brief interactive decision aid
- BEHAVIORAL Long video decision aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02625402 record still lists
NCT02625402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Brief interactive decision aid is the first listed.
NCT02625402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02625402 about?
NCT02625402 is a clinical study titled "Pilot RCT Comparing Effectiveness of Two Decision Aids for Hip and Knee Osteoarthritis". This pilot RCT study is to examine the comparative effectiveness of two decision aids for hip and knee osteoarthritis.
What is the current status of trial NCT02625402?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2015-12. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02625402?
The interventions under investigation include: Brief interactive decision aid (BEHAVIORAL), Long video decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT02625402?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02625402's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia